SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics

Olsen, Emily O’Malley; Roth, Nicole; Aveni, Kathryn; Santos, Pauline Dianne; Sizemore, Lindsey; Halai, Umme-Aiman; Nestoridi, Eirini; Barton, Jerusha; Mobley, Evan; Siebman, Samantha; Fussman, Chris; Mbotha, Deborah; Dzimira, Paula; Silcox, Kristin; Khuwaja, Salma; Roscom, Danacamile; Lush, Mamie; Chicchelly, Sarah; Delgado-López, Camille; Schlosser, Levi; Read, Jennifer S.; Ellington, Sascha; Hall, Aron J.; Gilboa, Suzanne M.; Tong, Van T.; Woodworth, Kate R.

doi:10.1111/ppe.12883

Cited by 17 publications

(12 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This activity was reviewed by the Centers for Disease Control and Prevention (CDC) and was conducted consistent with applicable federal law and CDC policy; the activity was determined to meet the requirements of public health surveillance as defined in 45 CFR 46.102(l) [ 2 ].…”

Section: Methodsmentioning

confidence: 99%

Critical care among newborns with and without a COVID-19 diagnosis, May 2020–February 2022

et al. 2023

Self Cite

View full text Add to dashboard Cite

Objective To assess COVID-19 association with newborn critical care outcomes, including nursery level of care and ventilation, during three time periods: Pre-delta (May 2020–June 2021), Delta (July–November 2021), and Omicron (December 2021–February 2022). Study design In a retrospective cohort of newborns born May 2020–February 2022 using the Premier Healthcare Database, we classified COVID-19 status and critical care using International Classification of Diseases 10th Revision and Current Procedural Terminology codes, laboratory data, and billing records and assessed for variation during three time periods. Results Of 1,388,712 newborns, 0.06% had COVID-19 during the birth hospitalization (Pre-delta period: 0.03%; Delta: 0.07%; Omicron: 0.21%). Among newborns with COVID-19, the risks for admission to a higher-level nursery and for invasive or non-invasive ventilation were lower in the Omicron period compared to Pre-delta and Delta periods. Conclusion From May 2020–February 2022, COVID-19 in newborns was rare and cases were less severe during the period of Omicron predominance.

show abstract

Section: Methodsmentioning

confidence: 99%

Critical care among newborns with and without a COVID-19 diagnosis, May 2020–February 2022

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…SET‐NET constitutes an adaptable mother–infant surveillance network, with general variables consistent across conditions, as well as modular data elements that allow for expansion to novel conditions (Woodworth et al, 2021). Most recently, SET‐NET data were used to describe SARS‐CoV‐2 testing patterns and positivity rates among neonates born to pregnant persons with SARS‐CoV‐2 infection during pregnancy, as well as infant outcomes through 6 months of age (Olsen et al, 2022; Gosdin et al, in press). During 2022–2023, CDC will fund five jurisdictions (Iowa, Minnesota, New Jersey, New York, and Utah) to pilot cCMV surveillance through SET‐NET.…”

Section: Discussionmentioning

confidence: 99%

Congenital cytomegalovirus surveillance in the United States

Raines

Heitman

Leung

et al. 2022

Birth Defects Research

Self Cite

View full text Add to dashboard Cite

Background Congenital cytomegalovirus (cCMV) is not a nationally notifiable condition, and little is known about how U.S. health departments (HDs) currently conduct cCMV surveillance. Methods We surveyed U.S. HDs that conduct cCMV surveillance or screening activities identified through a web‐based assessment. Meetings were held with each HD to enhance our understanding of survey responses. Results Ten states are systematically collecting cCMV case data to track cCMV cases during early infancy and to provide resources and services to families. Cases are ascertained using cCMV diagnostic codes, reported diagnosis, or laboratory results. Data elements collected for each case include demographics (all 10 states), clinical signs (8 states), laboratory data (4 states), treatment (4 states), and long‐term outcomes (1 state). Annual number of cases reported by HDs ranged from 3 to 47 cases/year in seven states, which was much lower than the expected number of cCMV cases. All 10 HDs have the ability to analyze data collected and four disseminate findings. Major challenges of surveillance reported by HDs were lack of standardized case definitions, personnel constraints, and limited funding. Conclusions A comprehensive account of cCMV disease burden is severely limited by low case ascertainment and paucity of data on long‐term outcomes. A standardized public health case definition for cCMV would improve consistency in measuring disease prevalence across jurisdictions and over time. Surveillance for cCMV has the potential to increase disease awareness and inform strategies to prevent cCMV‐associated disabilities.

show abstract

“…SARS-CoV-2 infection can cause mothers to have severe maternal diseases and preterm labor also happens frequently than it happens among healthy pregnant women. In Emily O'Malley Olsen et al study, 33 out of 138 cases which is 23.9% are having preterm labor among women with positive neonate RT-PCR test result, comparing with negative result population, the preterm infant rate is 15.3% that is 542 out of 3537 cases [11]. The preterm rate can reach 75% which means if mother infected with severe level of COVID-19 can cause high possibility of delivering preterm and illnesses on infants [12].…”

Section: Preterm / Vertical Transmissionmentioning

confidence: 98%

“…According to studies conducted by UW Medicine, placenta which transmit nutrition, immunity, and oxygen to the fetus, are easy to be infected or attacked by the SARS-CoV-2 virus [5]. Different variants of the COVID-19 virus cause different severity and Delta variant has been known causing a relative high stillbirth rate, maternal death rate, and hospitalizations comparing with other variants.…”

Section: Immunity Changesmentioning

confidence: 99%

See 1 more Smart Citation

The Impacts of the COVID-19 Pandemic on Pregnant Women

Peng¹

2023

HSET

View full text Add to dashboard Cite

The COVID-19 pandemic has many impacts on the society, such as the inadequacies and shortcomings of the current health system. There have been many reports pointing out that pregnant women are a vulnerable group to the severe COVID-19. Their bodies are more sensitive to the virus, that's for sure. According to a report from the University of Washington, the tissue structure of the placenta is vulnerable to the new coronavirus. And its role in the process of gestation is crucial. In addition, the physiological changes in pregnant women make it important for them to get enough oxygen. And it is the respiratory system that the novel coronavirus attacks. Early indiscrimination between COVID-19 and influenza also lead to worsening of illness caused by delayed treatment. Pregnant women, a vulnerable group, should be taken seriously and cared about in this environment, so that the health system needs to be changed. This article focuses on some severe cases of pregnant women caused by the novel coronavirus and the psychological and social pressure that pregnant women suffer in this environment.

show abstract

SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics

Cited by 17 publications

References 16 publications

Critical care among newborns with and without a COVID-19 diagnosis, May 2020–February 2022

Critical care among newborns with and without a COVID-19 diagnosis, May 2020–February 2022

Congenital cytomegalovirus surveillance in the United States

The Impacts of the COVID-19 Pandemic on Pregnant Women

Contact Info

Product

Resources

About